O

Ose Immunotherapeutics

Company profile · headcount, org chart & B2B contacts

21 Decision makers
+1 New (6 months)
200 Employees
$20M Revenue
2012 Founded

Organizational Chart of Ose Immunotherapeutics

Roles identified within Ose Immunotherapeutics's leadership team, based on public professional data.

Department

Ose Immunotherapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision-maker contacts at Ose Immunotherapeutics

Unlock emails & phones →

Decision makers at Ose Immunotherapeutics

21 identified 6 C-Level 1 VP 14 Directors +1 new (6 months)
See them on Zeliq →

Latest news at Ose Immunotherapeutics

  1. Appointment

    New Head of Translational Research appointed — Research

Get these new hires' email and phone →

Funding

Last round Other · $2M
Total funding $85M (12 rounds)
Post-IPO Equity $21M Mar 2015
Post-IPO Equity N/A Sep 2015
Post-IPO Equity $11M Dec 2016
Grant $11M Jul 2017
Grant $398K Dec 2017
Grant $430K Jul 2018
Grant $6M Dec 2020
Funding Round $13M May 2021
Debt Financing $12M Jul 2021
Grant $220K Aug 2023
Grant $9M Apr 2024
Grant $2M Jun 2025

Team Structure headcount by department

Research
20
Other
13
General Management
9
Medical
8
Project Management
7
Technical
7
Finance
4
Legal
4

Companies similar to Ose Immunotherapeutics

More companies to explore

Biotechnology Research · France

All Biotechnology Research companies in France →

About Ose Immunotherapeutics

Ose Immunotherapeutics operates in the Biotechnology Research industry, based in France. Established in 2012, it counts about 200 employees. Within the wider Professional Services sector, Ose Immunotherapeutics focuses on the Biotechnology Research segment. Its customer base is mainly professional: Ose Immunotherapeutics operates on a B2B model. To date, Ose Immunotherapeutics has completed 12 funding rounds totalling $85M. The company generates approximately $20M in annual revenue. This profile compiles key information about Ose Immunotherapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Ose Immunotherapeutics is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Ose Immunotherapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.

How to prospect Ose Immunotherapeutics's departments

Research

The company's largest department, with 20 people. Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Other

The company's second-largest department (13 people). Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

General Management

A team of 9 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Medical

This department counts 8 people. Time with patients is the priority: position your solution as a way to give hours back to care.

Project Management

7 people work in this department. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.

Technical

A team of 7 people. Skip the marketing speak: these decision makers expect precise use cases, documentation and a quick proof of value.

FAQ Ose Immunotherapeutics

What industry does Ose Immunotherapeutics operate in?

Ose Immunotherapeutics operates in the Biotechnology Research industry, specifically in the Professional Services category.

How many employees does Ose Immunotherapeutics have?

Ose Immunotherapeutics has approximately 200 employees (in the 51-200 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Ose Immunotherapeutics?

Zeliq helps you surface decision makers at Ose Immunotherapeutics, enrich them with verified emails and direct dials, and reach out through personalised multichannel prospecting sequences.

Where is Ose Immunotherapeutics headquartered?

Ose Immunotherapeutics is headquartered in France.

What is the organizational chart of Ose Immunotherapeutics?

Roles identified within Ose Immunotherapeutics's organization include CEO, CFO, Head of Finance, Directrice Cmc. With Zeliq, you can enrich each of these roles with verified emails and direct phone numbers.

Which decision makers recently joined Ose Immunotherapeutics?

In the last 6 months, Ose Immunotherapeutics appointed new decision makers including Head of Translational Research. Newly appointed leaders typically review tools and vendors early on — their verified contacts are available on Zeliq.

Why use this data before prospecting Ose Immunotherapeutics?

With Ose Immunotherapeutics's firmographics and business signals at hand, you can prioritise the account, personalise your approach, and contact the right people straight away.